Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

bioAffinity Technologies, Inc. (BIAF) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

bioAffinity Technologies, Inc. (BIAF), most recent 12 months reported: revenue $5.9M, net loss $15.19M, free cash flow -$11.56M. Latest balance sheet on file: liquid cash $2.43M, total debt $59.03K, net cash $2.37M. From SEC filings. Others in Services-Commercial Physical & Biological Research: NRC Health · OMNIAB, INC. · MaxCyte, Inc. · FOXO TECHNOLOGIES INC. · ABSCI CORP · ONEMEDNET CORPORATION · iSpecimen Inc. · CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.

Stock screener

Watchlist